Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its new ProPak™ GMP cytokines, alongside its portfolio of innovative products and solutions supporting cell and gene therapy ...

NSW Health advises HMPV is prone to resolving within one to 10 days of infection. Unlike Covid, the average person is likely ...

In a large-animal model study, researchers have found that heart attack recovery is aided by the injection of heart muscle ...

TOPLINE: Sjögren disease (SjD) presents three distinct phenotypes ― B-cell active with low symptom burden, high systemic ...

Familiar with the powerful influence of the gut–brain axis, Maraganore and his team set out to investigate how the ...

CytomX Therapeutics is shrinking its headcount by 40% as the biotech regroups and looks at fresh ways to conserve cash.

For a century, we believed that a normal temperature for a healthy person was 36.6°C (98.6°F). As it happens, though, there ...

This is the second volume of the Research Topic titled 'Novel Insights into CAR T-cell Associated Neurotoxicity'. You may ...

Dr. Sattva S. Neelapu discusses the intricacies of CAR T-cell therapy treatment and care for patients with hematologic ...

Cabaletta Bio’s financials and CAR T-cell therapy show potential but face risks. Discover why CABA stock is a risky yet ...

Hone Health provides a science-backed answer to the benefits and drawbacks of alcohol when it comes to life span and quality.

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced the opening ...